User profiles for Eric J. Topol
 | Eric TopolProfessor and EVP, Scripps Research Verified email at scripps.edu Cited by 350027 |
High-performance medicine: the convergence of human and artificial intelligence
EJ Topol - Nature medicine, 2019 - nature.com
The use of artificial intelligence, and the deep-learning subtype in particular, has been
enabled by the use of labeled big data, along with markedly enhanced computing power and …
enabled by the use of labeled big data, along with markedly enhanced computing power and …
AI in health and medicine
Artificial intelligence (AI) is poised to broadly reshape medicine, potentially improving the
experiences of both clinicians and patients. We discuss key findings from a 2-year weekly effort …
experiences of both clinicians and patients. We discuss key findings from a 2-year weekly effort …
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: Results at six months
Restenosis after coronary angioplasty occurs in at least 30% of patients in the first six months
and, as yet, there is no known treatment to decrease this event. We tested a monoclonal …
and, as yet, there is no known treatment to decrease this event. We tested a monoclonal …
[HTML][HTML] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
…, L Fabry-Ribaudo, J Booth, EJ Topol - … England Journal of …, 2006 - Mass Medical Soc
Background Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been
studied in a broad population of patients at high risk for atherothrombotic events. Methods We …
studied in a broad population of patients at high risk for atherothrombotic events. Methods We …
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
EJ Topol - The Lancet, 1998 - thelancet.com
Background Coronary stenting with use of heparin, aspirin, and ticlopidine for thromboprophylaxis
is performed in more than 500 000 patients per year worldwide. We did a randomised …
is performed in more than 500 000 patients per year worldwide. We did a randomised …
Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly throughout
the world since the first cases of coronavirus disease 2019 (COVID-19) were observed …
the world since the first cases of coronavirus disease 2019 (COVID-19) were observed …
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial
…, JT Mann III, ETA Fry, A DeLago, C Wilmer, EJ Topol… - Jama, 2002 - jamanetwork.com
ContextFollowing percutaneous coronary intervention (PCI), short-term clopidogrel therapy
in addition to aspirin leads to greater protection from thrombotic complications than aspirin …
in addition to aspirin leads to greater protection from thrombotic complications than aspirin …
Risk of cardiovascular events associated with selective COX-2 inhibitors
Atherosclerosis is a process with inflammatory features and selective cyclooxygenase 2 (COX-2)
inhibitors may potentially have antiatherogenic effects by virtue of inhibiting …
inhibitors may potentially have antiatherogenic effects by virtue of inhibiting …
Prevalence of conventional risk factors in patients with coronary heart disease
ContextIt is commonly suggested that more than 50% of patients with coronary heart disease
(CHD) lack any of the conventional risk factors (cigarette smoking, diabetes, hyperlipidemia…
(CHD) lack any of the conventional risk factors (cigarette smoking, diabetes, hyperlipidemia…
[HTML][HTML] Multimodal biomedical AI
The increasing availability of biomedical data from large biobanks, electronic health records,
medical imaging, wearable and ambient biosensors, and the lower cost of genome and …
medical imaging, wearable and ambient biosensors, and the lower cost of genome and …
